Achieve Life Sciences (ACHV) Tops Q3 EPS by 40c; Reports Cash and Cash Equivalents of $33.4M
Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.71), $0.40 better than the analyst estimate of ($1.11).
For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.